Fig.1 A work model of MCT4
MCT4 is an important protein on the cell membrane, which is structurally able to efflux lactic and pyruvic acids out of the cell, with the function of blocking itself in order to affect the acidity of the tumor microenvironments. It has recently identified that 7-aminocarboxycoumarin (7acc1) could act as a MCT4 inhibitor to block the lactate flux especially in MDA-MB231 cell line [1] [2].
Fig.2 Concentration basis for 7acc1 treatments
It was reported in vitro experiment that SiHa, HL60, MDA-MB231 cells were treated by 7acc1 (10 mol/L) for different time to inhibitor the function of MCT4, and also in vivo experiment, 7acc1 was daily injected intraperitoneally on breast cancer mice and tumor growth and mass was tracked [2] . A dose of 3 mg/kg/d was used on the basis of pilot pharmacokinetics studies that had shown that this dosage led to a Cmax > 1 mg/mL and a plasma half-life of 4.5 hours [1] . The MW of 7acc1 is 261.27, which is considered suitable to select a conversion coefficient 300.
In our study, the concentrations of 7acc1 in our study were based on the above data. In vivo experiment, we injected 7acc1 intraperitoneal with the concentration gradient: 0.3, 0.03 and 0.003 mg/kg. In vitro experiment, we use this following concentration gradient: 0.1, 0.01, and 0.001 mmol/L.
